Member Info for PlantPower

Circa 1.9m left as of last Friday with another chunk gone today

RNS - BGF down to 3.387% as expected.

reckon close - 139p just paid, so let's see...

JH - well played on NCYT.

last of CLN maybe....done well to get 135p - shows strong demand.

250k vol at 135 sell just printed...

Agreed @lloyd88 - 1.1m already (before 11am!)

into Auction.....

Ha - me too bigAl

Little wriggler nearly jumped out the keep net ;0)

141 paid

BOOOOOMMMMMMM

139.7 paid

101k vol sell looks like a buy

138 paid

Ask up to 140...

136 paid

135.99

135.97...

And more importantly PEEL On BID

135.34 paid...

Repost - but may be of interest for any new joiners:

“
https://www.bbc.co.uk/programmes/p002vsnb/episodes/player

Episode - Are children the biggest COVID-19 spreaders?

Good listen for those that are interested.

Interesting the chap interviewed from university of Padur stated they are currently running 5k (25min 30secs in) per RT-PCR tests per day (presume due to capacity constraints rather than demand and making presumption non automated).

- GDR can produce 10k per hour (clearly could be more in future).
- If we use same 5K per day figure, and apply to solely India (non-automated method)
- DIVOC planning on 20 labs up and running by year end.
- India non-automated = 5k x 20 labs = 100k tests per day
- GDR Rev @£9 per test (may be less) = £900k rev per day / £328.50m rev per year / £197m profit per year @ 60% margin

Above is only India non-automated - not accounting for any US or Africa.

Even if above is overstating India based on number of labs (and or price per test & margin slight variable), you would think factoring in automation and US/Africa could feasibly yield those stats.

That’s ignoring all other products / sales coming to fruition in Autumn.

£1.08 - 61 mcap, seems a tad cheap don’t you think??”

Clearly we’re now at 129p....but still holds true!

PP

Newsflow(s) imminent / technicals good / macro environment positive from GDR investment perspective / MCAP very low / CLN churn complete or nearly complete (current tranche) / fully funded / strong collaborations in place / strategically targeted geographies - US/India/Africa / automated PCR SWAB (nasal/throat) imminent followed by saliva (spit - game changer) in validation / POC to follow (based on existing tech) / multiple non-Covid newsflow due in autumn / 129p - sounds a tad cheap.

PP

Nearly 1mill vol delayed from yesterday....wowsa